SuspendedNot Applicable

Glucose and Blood Pressure During Pregnancy

Stopped: Awaiting device from Sponsor

United States100 participantsStarted 2026-08

Plain-language summary

The purpose of this research is to examine the beneficial effects of regular, non-invasive, glucose (sugar) assessment on glucose (sugar) and blood pressure regulation during pregnancy to help in predicting gestational diabetes and preeclampsia.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age range: 18-45 years (inclusive) * Body mass index (BMI) ≤40kg/m2 * \>1 risk factor for GDM * \<16wks gestation * Gender: only females will be recruited into this study * Ability to provide written informed consent Exclusion Criteria: * Presence of chronic kidney disease (creatinine \>2.5mg/dL) and/or active cancer * Smoking * Multiple pregnancies * Congenital abnormalities * Use of chronic medications which influence blood \[glucose\] or \[insulin\] * Subsequent diagnosis of GDM or preeclampsia

What they're measuring

Blood Glucose

Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, Week 24, Week 30

Systolic Blood Pressure

Timeframe: Baseline

Diastolic Blood Pressure

Timeframe: Baseline

Trial details

NCT IDNCT04979312

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Gestational Diabetes trials